{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:46:59Z","timestamp":1782492419506,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41401-018-0044-4","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T10:22:54Z","timestamp":1532082174000},"page":"589-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy"],"prefix":"10.1038","volume":"40","author":[{"given":"Qian","family":"LI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-ming","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-ya","family":"SUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-ping","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-xia","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"GUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-wei","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-tao","family":"YE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"LU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-qing","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"44_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1476-5381.2012.01903.x","volume":"168","author":"SS Yu","year":"2013","unstructured":"Yu SS, Cai Y, Ye JT, Pi RB, Chen SR, Liu PQ, et al. Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-\u03baB-dependent transcriptional activity. Br J Pharmacol. 2013;168:117\u201328.","journal-title":"Br J Pharmacol"},{"key":"44_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","volume":"109","author":"N Frey","year":"2004","unstructured":"Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target. Circulation. 2004;109:1580\u20139.","journal-title":"Circulation"},{"key":"44_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/hrt.73.6.496","volume":"73","author":"PE Glennon","year":"1995","unstructured":"Glennon PE, Sugden PH, Poole-Wilson PA. Cellular mechanisms of cardiac hypertrophy. Br Heart J. 1995;73:496\u20139.","journal-title":"Br Heart J"},{"key":"44_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/cvr\/cvt128","volume":"99","author":"A Funayama","year":"2013","unstructured":"Funayama A, Shishido T, Netsu S, Narumi T, Kadowaki S, Takahashi H, et al. Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure. Cardiovasc Res. 2013;99:657\u201364.","journal-title":"Cardiovasc Res"},{"key":"44_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12672-014-0175-0","volume":"5","author":"M Srinivasan","year":"2014","unstructured":"Srinivasan M, Banerjee S, Palmer A, Zheng G, Chen A, Bosland MC, et al. HMGB1 in hormone-related cancer: a potential therapeutic target. Horm Cancer. 2014;5:127\u201339.","journal-title":"Horm Cancer"},{"key":"44_CR6","first-page":"541394","volume":"2014","author":"ZK Jia","year":"2014","unstructured":"Jia ZK, Xue R, Liu GQ, Li L, Yang JJ, Pi GF, et al. HMGB1 is involved in the protective effect of the PPAR\u03b1 agonist fenofibrate against cardiac hypertrophy. PPAR Res. 2014;2014:541394.","journal-title":"PPAR Res"},{"key":"44_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neulet.2016.11.047","volume":"645","author":"YF Li","year":"2017","unstructured":"Li YF, Li XH, Qu Y, Huang JC, Zhu TT, Zhao FY, et al. Role of HMGB1 translocation to neuronal nucleus in rat model with septic brain injury. Neurosci Lett. 2017;645:90\u20136.","journal-title":"Neurosci Lett"},{"key":"44_CR8","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1161\/CIRCULATIONAHA.107.757443","volume":"118","author":"K Takahashi","year":"2008","unstructured":"Takahashi K, Fukushima S, Yamahara K, Yashiro K, Shintani Y, Coppen SR, et al. Modulated inflammation by injection of high-mobility group box 1 recovers post-Infarction chronically failing heart. Circulation. 2008;118:S106\u2013114.","journal-title":"Circulation"},{"key":"44_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cvr\/cvn291","volume":"81","author":"T Kohno","year":"2009","unstructured":"Kohno T, Anzai T, Naito K, Miyasho T, Okamoto M, Yokota H, et al. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc Res. 2009;81:565\u201373.","journal-title":"Cardiovasc Res"},{"key":"44_CR10","first-page":"620","volume":"24","author":"YT Tang","year":"2016","unstructured":"Tang YT, Zhao X, Daniel A, Xiao XZ, Wang HC, Ulf A, et al. Regulation of posttranslational modifications of HMGB1 during immune responses. Antioxid Redox Sign. 2016;24:620\u201334.","journal-title":"Sign"},{"key":"44_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jcmm.12743","volume":"20","author":"L Zhang","year":"2016","unstructured":"Zhang L, Liu M, Jiang H, Yu Y, Yu P, Tong R, et al. Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure. J Cell Mol Med. 2016;20:459\u201370.","journal-title":"J Cell Mol Med"},{"key":"44_CR12","first-page":"805149","volume":"2012","author":"FF Su","year":"2012","unstructured":"Su FF, Shi MQ, Guo WG, Liu XT, Wang HT, Lu ZF, et al. High-mobility group box 1 induces calcineurin-mediated cell hypertrophy in neonatal rat ventricular myocytes. Mediat Inflamm. 2012;2012:805149.","journal-title":"Mediat Inflamm"},{"key":"44_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/1-4020-5466-1_3","volume":"41","author":"DA Wacker","year":"2007","unstructured":"Wacker DA, Frizzell KM, Zhang T, Kraus WL. Regulation of chromatin structure and chromatin-dependent transcription by poly(ADP-ribose) polymerase-1: possible targets for drug-based therapies. Subcell Biochem. 2007;41:45\u201369.","journal-title":"Subcell Biochem"},{"key":"44_CR14","doi-asserted-by":"publisher","first-page":"7475","DOI":"10.1128\/MCB.01314-07","volume":"27","author":"DA Wacker","year":"2007","unstructured":"Wacker DA, Ruhl DD, Balagamwala EH, Hope KM, Zhang T, Kraus WL. The DNA binding and catalytic domains of poly(ADP-Ribose) polymerase 1 cooperate in the regulation of chromatin structure and transcription. Mol Cell Biol. 2007;27:7475\u201385.","journal-title":"Mol Cell Biol"},{"key":"44_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.molcel.2010.08.014","volume":"39","author":"R Krishnakumar","year":"2010","unstructured":"Krishnakumar R, Kraus WL. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell. 2010;39:736\u201349.","journal-title":"Mol Cell"},{"key":"44_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nbd.2014.05.023","volume":"70","author":"E Gerace","year":"2014","unstructured":"Gerace E, Masi A, Resta F, Felici R, Landucci E, Mello T, et al. PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca2+-permeable AMPA receptors. Neurobiol Dis. 2014;70:43\u201352.","journal-title":"Neurobiol Dis"},{"key":"44_CR17","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/ncb1638","volume":"9","author":"M Kanai","year":"2007","unstructured":"Kanai M, Hanashiro K, Kim SH, Hanai S, Boulares AH, Miwa M, et al. Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation. Nat Cell Biol. 2007;9:1175\u201383.","journal-title":"Nat Cell Biol"},{"key":"44_CR18","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1128\/MCB.01746-07","volume":"28","author":"OA Olabisi","year":"2008","unstructured":"Olabisi OA, Soto-Nieves N, Nieves E, Yang TT, Yang X, Yu RY, et al. Regulation of transcription factor NFAT by ADP-ribosylation. Mol Cell Biol. 2008;28:2860\u201371.","journal-title":"Mol Cell Biol"},{"key":"44_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.molcel.2010.10.029","volume":"40","author":"P L\u00f6nn","year":"2010","unstructured":"L\u00f6nn P, van der Heide LP, Dahl M, Hellman U, Heldin CH, Moustakas A. PARP-1 attenuates Smad-mediated transcription. Mol Cell. 2010;40:521\u201332.","journal-title":"Mol Cell"},{"key":"44_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bbrc.2009.03.022","volume":"382","author":"J Sakamaki","year":"2009","unstructured":"Sakamaki J, Daitoku H, Yoshimochi K, Miwa M, Fukamizu A. Regulation of FOXO1-mediated transcription and cell proliferation by PARP-1. Biochem Bioph Res Commun. 2009;382:497\u2013502.","journal-title":"Biochem Bioph Res Commun"},{"key":"44_CR21","doi-asserted-by":"publisher","first-page":"28675","DOI":"10.1074\/jbc.M115.661611","volume":"290","author":"X Luo","year":"2015","unstructured":"Luo X, Nie J, Wang S, Chen Z, Chen W, Li D, et al. Poly(ADP-ribosyl) ation of FOXP3 protein mediated by PARP-1 protein regulates the function of regulatory T cells. J Biol Chem. 2015;290:28675\u201382.","journal-title":"J Biol Chem"},{"key":"44_CR22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.cell.2004.11.017","volume":"119","author":"BG Ju","year":"2004","unstructured":"Ju BG, Solum D, Song EJ, Lee KJ, Rose DW, Glass CK, et al. Activating the PARP-1 sensor component of the groucho\/TLE1 corepressor complex mediates a CaMKinase IIdelta-dependent neurogenic gene activation pathway. Cell. 2004;119:815\u201329.","journal-title":"Cell"},{"key":"44_CR23","doi-asserted-by":"publisher","first-page":"H1545","DOI":"10.1152\/ajpheart.01124.2005","volume":"291","author":"JB Pillai","year":"2006","unstructured":"Pillai JB, Gupta M, Rajamohan SB, Lang R, Raman J, Gupta MP. Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2006;291:H1545\u2013H1553.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"44_CR24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/aps.2016.159","volume":"38","author":"GS Feng","year":"2017","unstructured":"Feng GS, Zhu CG, Li ZM, Wang PX, Huang Y, Liu M, et al. Synthesis of the novel PARP-1 inhibitor AG-690\/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling. Acta Pharmacol Sin. 2017;38:638\u201350.","journal-title":"Acta Pharmacol Sin"},{"key":"44_CR25","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.bbamcr.2016.09.019","volume":"1863","author":"J Lu","year":"2016","unstructured":"Lu J, Zhang RW, Hong HQ, Yang ZL, Sun DP, Sun SY, et al. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy. Biochim Biophys Acta. 2016;1863:3027\u201339.","journal-title":"Biochim Biophys Acta"},{"key":"44_CR26","doi-asserted-by":"publisher","first-page":"17845","DOI":"10.1074\/jbc.M701465200","volume":"282","author":"D Ditsworth","year":"2007","unstructured":"Ditsworth D, Zong WX, Thompson CB. Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus. J Biol Chem. 2007;282:17845\u201354.","journal-title":"J Biol Chem"},{"key":"44_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.trsl.2016.03.002","volume":"172","author":"J Lu","year":"2016","unstructured":"Lu J, Sun DP, Liu ZP, Li M, Hong HQ, Liu C, et al. SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy. Transl Res. 2016;172:96\u2013112.e6.","journal-title":"Transl Res"},{"key":"44_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.yexcr.2016.07.006","volume":"347","author":"ZB Yue","year":"2016","unstructured":"Yue ZB, Ma YZ, You J, Li ZM, Ding YQ, He P, et al. NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiachypertrophy. Exp Cell Res. 2016;347:261\u201373.","journal-title":"Exp Cell Res"},{"key":"44_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jphs.2016.03.013","volume":"132","author":"PY Shen","year":"2016","unstructured":"Shen PY, Feng XJ, Zhang XY, Huang XY, Liu SL, Lu X, et al. SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300. J Pharmacol Sci. 2016;132:31\u201340.","journal-title":"J Pharmacol Sci"},{"issue":"4","key":"44_CR30","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1002\/jcb.26649","volume":"120","author":"Shuya Sun","year":"2019","unstructured":"Sun SY, Hu YH, Zheng QY, Guo Z, Sun DP, Chen SR, et al. PARP1 induces cardiac fibrosis by mediating mTOR activity. J Cell Biochem. 2017. \n                    https:\/\/doi.org\/10.1002\/jcb.26649\n                    \n                  .","journal-title":"Journal of Cellular Biochemistry"},{"key":"44_CR31","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.ijcard.2013.01.165","volume":"168","author":"J Gravning","year":"2013","unstructured":"Gravning J, Ahmed MS, von Lueder TG, Edvardsen T, Attramadal H. CCN2\/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload. Int J Cardiol. 2013;168:2049\u201356.","journal-title":"Int J Cardiol"},{"key":"44_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/FJC.0000000000000404","volume":"68","author":"XY Zhang","year":"2016","unstructured":"Zhang XY, Li W, Shen PY, Feng XJ, Yue ZB, Lu J, et al. STAT3 suppression is involved in the protective effect of SIRT6 against cardiomyocyte hypertrophy. J Cardiovasc Pharmacol. 2016;68:204\u201314.","journal-title":"J Cardiovasc Pharm"},{"key":"44_CR33","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1111\/bph.13091","volume":"172","author":"XJ Feng","year":"2015","unstructured":"Feng XJ, Gao H, Gao S, Li ZM, Li H, Lu J, et al. The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1. Br J Pharmacol. 2015;172:2852\u201363.","journal-title":"Brit J Pharmacol"},{"key":"44_CR34","doi-asserted-by":"publisher","first-page":"E4079","DOI":"10.1073\/pnas.1315587110","volume":"110","author":"C Putinski","year":"2013","unstructured":"Putinski C, Abdul-Ghani M, Stiles R, Brunette S, Dick SA, Fernando P, et al. Intrinsic-mediated caspase activation is essential for cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A. 2013;110:E4079\u20134087.","journal-title":"Proc Natl Acad Sci USA"},{"key":"44_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/SHK.0000000000000309","volume":"43","author":"CX Wu","year":"2015","unstructured":"Wu CX, He LX, Guo H, Tian XX, Liu Q, Sun H. Inhibition effect of glycyrrhizen in lipopolysaccharide-induced high-mobility group box 1 releasing and expression from RAW264.7 cells. Shock. 2015;43:412\u201321.","journal-title":"Shock"},{"key":"44_CR36","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.4049\/jimmunol.1400359","volume":"193","author":"ZY Yang","year":"2014","unstructured":"Yang ZY, Li L, Chen LJ, Yuan WW, Dong LM, Zhang YS, et al. PARP-1 mediates LPS-induced HMGB1 release by macrophages through regulation of HMGB1 acetylation. J Immunol. 2014;193:6114\u201323.","journal-title":"J Immunol"},{"key":"44_CR37","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.phrs.2016.06.031","volume":"111","author":"E Venereau","year":"2016","unstructured":"Venereau E, De Leo F, Mezzapelle R, Careccia G, Musco G, Bianchi ME. HMGB1 as biomarker and drug target. Pharmacol Res. 2016;111:534\u201344.","journal-title":"Pharmacol Res"},{"key":"44_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yjmcc.2016.02.002","volume":"93","author":"J Ren","year":"2016","unstructured":"Ren J, Xu XH, Wang QR, Ren SY, Dong ML, Zhang YM. Permissive role of AMPK and autophagy in adiponectin deficiency-accentuated myocardial injury and inflammation in endotoxemia. J Mol Cell Cardiol. 2016;93:18\u201331.","journal-title":"J Mol Cell Cardiol"},{"key":"44_CR39","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/tox.22267","volume":"32","author":"YH Lei","year":"2017","unstructured":"Lei YH, Li X, Yuan F, Liu L, Zhang J, Yang YP, et al. Toll-like receptor 4 ablation rescues against paraquat-triggered myocardial dysfunction: role of ER stress and apoptosis. Environ Toxicol. 2017;32:656\u201368.","journal-title":"Environ Toxicol"},{"key":"44_CR40","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1038\/cdd.2016.99","volume":"23","author":"C Yu","year":"2016","unstructured":"Yu C, Kim BS, Kim E. FAF1 mediates regulated necrosis through PARP1 activation upon oxidative stress leading to dopaminergic neurodegeneration. Cell Death Differ. 2016;23:1873\u201385.","journal-title":"Cell Death Differ"},{"key":"44_CR41","doi-asserted-by":"publisher","first-page":"10209","DOI":"10.1073\/pnas.1405158111","volume":"111","author":"SA Andrabi","year":"2014","unstructured":"Andrabi SA, Umanah GK, Chang C, Stevens DA, Karuppagounder SS, Gagn\u00e9 JP, et al. Poly (ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Proc Natl Acad Sci U S A. 2014;111:10209\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"44_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/cvr\/cvp144","volume":"83","author":"E Bartha","year":"2009","unstructured":"Bartha E, Solti I, Kereskai L, Lantos J, Plozer E, Magyar K, et al. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats. Cardiovasc Res. 2009;83:501\u201310.","journal-title":"Cardiovasc Res"},{"key":"44_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4161\/15548627.2014.994400","volume":"11","author":"MH Yang","year":"2015","unstructured":"Yang MH, Liu LY, Xie M, Sun XF, Yu Y, Kang R, et al. Poly-ADP-ribosylation of HMGB1 regulates TNFSF10\/TRAIL resistance through autophagy. Autophagy. 2015;11:214\u201324.","journal-title":"Autophagy"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0044-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0044-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0044-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:02Z","timestamp":1684616462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0044-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["44"],"URL":"https:\/\/doi.org\/10.1038\/s41401-018-0044-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,20]]},"assertion":[{"value":"3 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}